Collaboration Agreement (Details) $ in Millions |
1 Months Ended | 3 Months Ended |
|---|---|---|
|
Nov. 30, 2022
item
|
Mar. 31, 2026
USD ($)
|
|
| LigaChem Biosciences | ||
| Collaboration Agreements | ||
| Additional receivable on collaboration agreements, finalization of cost sharing | $ 0.6 | |
| Research Collaboration and Co-Development Agreement | ||
| Collaboration Agreements | ||
| Maximum number of antibody drug conjugates to be developed | item | 3 | |
| Collaboration agreements cost sharing percentage (as a percent) | 50.00% | 50.00% |
| Collaboration arrangement reduction in expenses | $ 0.6 |